CorMedix Inc. CRMD shares are trading lower by 23.27% to $3.89 Thursday morning after the company priced its public offering of 7.5 million shares at $4 per share and pre-funded warrants to purchase up to 2.5 million shares at $3.999 per pre-funded warrant.
What Else?
The total gross proceeds to the company are anticipated to be around $40 million, before deducting underwriting discounts, commissions and other expenses.
See Also: Why Micron Stock Is Moving Higher Today
CorMedix has also granted the underwriters a 30-day option to acquire an additional 1,500,093 shares of common stock.
The closing of the offering is expected to take place on or around July 3, subject to customary closing conditions.
According to data from Benzinga Pro, CRMD has a 52-week high of $8.02 and a 52-week low of $2.71.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
